UNITED  STATES
                       SECURITIES  AND  EXCHANGE  COMMISSION
                             WASHINGTON,  D.C.  20549

                                   FORM  12B-25
                          COMMISSION  FILE  NUMBER-0-21931
                           NOTIFICATION  OF  LATE  FILING

(CHECK  ONE)
  X   FORM  10-K  AND  FORM  10-KSB    FORM  20-F     FORM  11-K     FORM  10-Q
 --                                 ---            ---           ---
       AND  FORM  10-QSB    FORM N-SAR
                         ---

                  FOR  PERIOD  ENDED  DECEMBER  31,  2002
                                     ---------------------
                  __  TRANSITION  REPORT  ON  FORM  10-K  AND  FORM  10-KSB
                  __  TRANSITION  REPORT  ON  FORM  20-F
                  __  TRANSITION  REPORT  ON  FORM  11-K
                  __  TRANSITION  REPORT  ON  FORM  10-Q  AND  FORM  10-QSB
                  __  TRANSITION  REPORT  ON  FORM  N-SAR
                  FOR  THE  TRANSITION  PERIOD  ENDED:  ___________________

             READ  INSTRUCTIONS  (ON  BACK  PAGE)  BEFORE  PREPARING  FORM.
                              PLEASE  PRINT  OR  TYPE.

     NOTHING  IN  THIS  FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION HAS
VERIFIED  ANY  INFORMATION  CONTAINED  HEREIN.

     IF  THE  NOTIFICATION  RELATES  TO  A  PORTION OF THE FILING CHECKED ABOVE,
IDENTIFY  THE  ITEM(S)  TO  WHICH  THE  NOTIFICATION  RELATES:  _______________
______________________________________________________________________________



PART  I--REGISTRANT  INFORMATION

Full  Name  of  Registrant:            AMPLIDYNE,  INC.
                             ------------------------------

Former  Name  of  Registrant:
                             ------------------------------

Address  of  Principal  Executive  Office  (Street  and  Number):

59  LaGrange  Street,  Raritan,  New  Jersey  08869
--------------------------------------------------------------




PART  II--RULES  12B-25(b)  AND  (c)

If  the subject report could not be filed without unreasonable effort or expense
and  the  registrant seeks relief pursuant to Rule 12b-25b, the following should
be  completed.  (Check  box  if  appropriate):

[X]     (a)     The  reasons  described in reasonable detail in Part III of this
form  could  not  be  eliminated  without  unreasonable  effort  or  expense;

[X]     (b)     The subject annual report, semi-annual report, transition report
on  Forms 10-K, 10-KSB, Form 20-F, 11-K, Form N-SAR, or portion thereof, will be
filed on or before the fifteenth calendar day following the prescribed due date;
or  the  subject quarterly report or transition report on Forms 10-Q, 10-QSB, or
portion  thereof will be filed on or before the fifth calendar day following the
prescribed  due  date;  and

[  ]     (c)     The  accountant's  statement  or other exhibit required by Rule
12b-25(c)  has  been  attached  if  applicable.

PART  III--NARRATIVE

State  below  in reasonable detail the reasons why the Forms 10-K, 10-KSB, 20-F,
11-K,  10-Q,10-QSB,  N-SAR,  or  the transition report or portion thereof, could
not  be filed  within  the  prescribed  time  period.  (ATTACH  EXTRA  SHEETS IF
NEEDED)

     The  Company  has not been able to compile the requisite financial data and
other  narrative  information  necessary to enable it to have sufficient time to
complete  the  Company's  Annual  Report  on  Form 10-KSB by March 31, 2002, the
required  filing  date,  without  unreasonable  effort  and  expense.

PART  IV--OTHER  INFORMATION

(1)     Name  and  telephone  number  of  person  to  contact  in regard to this
notification

     Devendar  S.  Bains             (908)             253-6870
     ------------------          --------        -----------------
     (NAME)                    (AREA  CODE)     (TELEPHONE  NUMBER)

(2)  Have  all  other  periodic  reports  required  under Section 13 or 15(d) of
the  Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
of  1940  during  the  preceding  12 months (or for such shorter period that the
registrant  was  required  to  file  such reports) been filed?  If answer is no,
identify  report(s).      X  Yes      No
                         ---      ---


(3)     Is  it  anticipated that any significant change in results of operations
from  the corresponding period for the last fiscal year will be reflected by the
earnings  statements  to  be  included in the subject report or portion thereof?
                                                 X  Yes       No
                                                ---       ---

     If  so,  attach  an explanation of the anticipated change, both narratively
and  quantitatively,  and,  if  appropriate,  state the reasons why a reasonable
estimate  of  the  results  cannot  be  made.

     Preliminary  results  of  operations  indicate  the loss for the year ended
December  31,  2002  is estimated to be approximately $2,318,000 compared to the
loss  for  the  preceding  year  of  $2,024,882,representing  an  increase  of
approximately  $293,000 or 14%. The increased loss is primarily attributable to:
sales  decline  of approximately $592,000; write-down of inventory in the second
quarter of approximately $235,000 with the balance attributable to reduced gross
profit  margins  and  investment  income as well as a $25,000 decrease in income
from  the sale of state tax credits. Losses were in part mitigated by a decrease
in  research  expenditures  of  approximately  $167,000  and  and  a decrease of
$406,000  in  litigation  losses.





                                 AMPLIDYNE,  INC.
                   ---------------------------------------
                (Name  of  Registrant  as  Specified  In  Charter)

has  caused  this  notification  to  be  signed on its behalf by the undersigned
hereto  duly  authorized


Dated:  March  31,  2003             AMPLIDYNE,  INC.


                                 By:  /s/  Devendar  S.  Bains
                                     -----------------------------
                                     Devendar  S. Bains, Chief Executive Officer

INSTRUCTION: The form may be signed by an executive officer of the registrant or
by  any  other duly authorized representative.  The name and title of the person
signing  the  form  shall  be  typed  or  printed beneath the signature.  If the
statement  is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign  on  behalf  of  the  registrant  shall  be  filed  with  the  form.


                                    ATTENTION

     INTENTIONAL  MISSTATEMENTS OR OMISSIONS OF FACT CONSTITUTE FEDERAL CRIMINAL
VIOLATIONS  (SEE  18  U.S.C.  1001).

                              GENERAL  INSTRUCTIONS

1.     This  form  is required by Rule 12b-25 (17 CFR 240.12b-25) of the General
Rules  and  Regulations  under  the  Securities  Exchange  Act  of  1934.

2.     One signed original and four conformed copies of this form and amendments
thereto must be completed and filed with the Securities and Exchange Commission,
Washington,  D.C.  20549,  in  accordance with Rule 0-3 of the General Rules and
Regulations  under the Act.  The information contained in or filed with the form
will  be  made  a  matter  of  public  record  in  the  Commission  files.

3.     A  manually signed copy of the form and amendments thereto shall be filed
with  each  national securities exchange on which any class of securities of the
registrant  is  registered.

4.     Amendments  to  the  notifications  must also be filed on form 12b-25 but
need  not restate information that has been correctly furnished.  The form shall
be  clearly  identified  as  an  amendment  notification.